37
Views
0
CrossRef citations to date
0
Altmetric
Review

Gaps in patients’ understanding of palliative chemotherapy. Can we better communicate that treatment is not curative?

Pages 245-249 | Received 17 Jul 2017, Accepted 04 Sep 2017, Published online: 11 Sep 2017

References

  • Gattellari M, Butow P, Tattersall MHN, et al. Misunderstanding in cancer patients: why shoot the messenger? Ann Oncol. 1999;10:39–46.
  • Gattellari M, Voigt KJ, Butow PN, et al. When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol. 2002;20:503–513.
  • Weeks JC, Catalano PJ, Cronin A, et al. Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012;367:1616–1625.
  • Dimoska A, Tattersall MHN, Butow PN, et al. Can a “prompt list” empower cancer patients to ask relevant questions? Cancer. 2008;113(2):225–237.
  • Brandes K, Butow PN, Tattersall MH, et al. Advanced cancer patients’ and caregivers’ use of a question prompt list. Patient Educ Couns. 2014;97:30–37.
  • Walczak A, Mazer B, Butow PN, et al. A question prompt list for patients with advanced cancer in the final year of life: development and cross-cultural evaluation. Palliat Med. 2013;27:779–788.
  • Weeks JC, Cook EF, O’Day SJ, et al. Relationship between cancer patients’ predictions of prognosis and their treatment preferences. Jama. 1998;279:1709–1714.
  • Kiely BE, Soon YY, Tattersall MHN, et al. How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials. J Clin Oncol. 2010;29:456–463.
  • Kiely BE, Tattersall Martin HN, Stockler MR. Certain death in uncertain time: informing hope by quantifying a best case scenario. J Clin Oncol. 2010;28:2802–2804.
  • Kiely BE, Martin AJ, Tattersall MHN, et al. The median informs the message: accuracy of individualized scenarios for survival time based on oncologists’ estimates. J Clin Oncol. 2013;31:3565–3571.
  • Kiely BE, Alam M, Blinmen P, et al. Estimating typical best case, worst case life expectancy scenarios for patients starting chemotherapy for advanced non small cell lung cancer. A systematic review of contemporary randomised trials. Lung Cancer. 2012;77(3):537–544.
  • Kiely BE, McCaughan G, Christodoulou S, et al. Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Support Care Cancer. 2013;21:369–376.
  • Ahn E, Shin D, Choi JY, et al. The impact of awareness of terminal illness on quality of death and care decision making: a prospective nationwide survey of bereaved family members of advanced cancer patients. PschoOncol. 2013;22:2771–2778.
  • Chochinov HM, Tataryn DJ, Wilson KG, et al. Prognostic awareness and the terminally ill. Psychosomatics. 2000;41:500–504.
  • Mack J, Wolfe J, Cook E, et al. Hope and prognostic disclosure. J Clin Oncol. 2007;25:5636–5642.
  • Roberts C, Benjamin H, Chen L, et al. Assessing communication between oncology professionals and their patients. J Cancer Educ. 2005;20:113–118.
  • Greisinger AJ, Lorimor RJ, Aday LA, et al. Terminally ill cancer patients: their most important concerns. Cancer Pract. 1997;5(3):147–154.
  • Epstein RM, Duberstein PR, Fenton JJ, et al. Effect of a patient-centered communication intervention on oncologist-patient communication, qualify of life, and health care utilization in advanced cancer. The VOICE randomized clinical trial. JAMA Oncol. 2016 [cited Sep 9]. DOI:10.100/jamaoncol.2016.4373
  • Gramling R, Fiscella K, Xing G, et al. Determinants of patient-oncologist prognostic discordance in advanced cancer. JAMA Oncol. 2016;2(11):1421–1426.
  • Robinson JD, Jagsi R. Physician-patient communication – an actionable target for reducing overly aggressive care near the end of life. JAMA Oncol. 2016;2(11):1407–1408.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.